{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:51:07Z","timestamp":1790549467170,"version":"4.1.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0201517","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T13:42:38Z","timestamp":1533130958000},"page":"e0201517","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7415-0787","authenticated-orcid":true,"given":"Nicolas","family":"Clementy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mentine","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Bisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazih","family":"Benhenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Piver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Babuty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"P Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jacc.2015.08.038","article-title":"Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management","volume":"66","author":"R Gopinathannair","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jama.2014.3","article-title":"Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study","volume":"311","author":"NF Marrouche","year":"2014","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/eurheartj\/eht194","article-title":"Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy","volume":"34","author":"H Kottkamp","year":"2013","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcme.2014.10.003","article-title":"Galectin-3 in patients undergoing ablation of atrial fibrillation","volume":"5","author":"N Clementy","year":"2014","journal-title":"IJC Metab Endocrinol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ahj.2014.02.009","article-title":"Galectin 3 and incident atrial fibrillation in the community","volume":"167","author":"JE Ho","year":"2014","journal-title":"Am Heart J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/heartjnl-2015-308975","article-title":"Serial galectin-3 and future cardiovascular disease in the general population","volume":"102","author":"AR van der Velde","year":"2016","journal-title":"Heart"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"34357","DOI":"10.1038\/srep34357","article-title":"Serum Galectin-3 Levels Predict Recurrences after Ablation of Atrial Fibrillation","volume":"6","author":"N Clementy","year":"2016","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/europace\/euv045","article-title":"Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease","volume":"17","author":"XY Wu","year":"2015","journal-title":"Europace"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","article-title":"Galectin-3: a novel mediator of heart failure development and progression","volume":"11","author":"RA de Boer","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1586\/14737159.2014.892421","article-title":"The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure","volume":"14","author":"WC Meijers","year":"2014","journal-title":"Expert Rev Mol Diagn"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.hrthm.2005.11.012","article-title":"Long-term evaluation of atrial fibrillation ablation guided by noninducibility","volume":"3","author":"P Ja\u00efs","year":"2006","journal-title":"Heart Rhythm"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jacbts.2016.03.003","article-title":"Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes","volume":"1","author":"Y Takemoto","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e0189936","DOI":"10.1371\/journal.pone.0189936","article-title":"Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study","volume":"13","author":"GA Begg","year":"2018","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/eurheartj\/ehi066","article-title":"Functional impact of rate irregularity in patients with heart failure and atrial fibrillation receiving cardiac resynchronization therapy","volume":"26","author":"V Melenovsky","year":"2005","journal-title":"Eur Heart J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJMoa0708234","article-title":"Pulmonary-vein isolation for atrial fibrillation in patients with heart failure","volume":"359","author":"MN Khan","year":"2008","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.hlc.2015.02.025","article-title":"Pulmonary Vein Isolation Compared to Rate Control in Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis","volume":"24","author":"K Vaidya","year":"2015","journal-title":"Heart Lung Circ"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial","volume":"133","author":"L Di Biase","year":"2016","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.CIR.0000135472.28234.CC","article-title":"Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia","volume":"110","author":"P Nerheim","year":"2004","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jacc.2006.03.056","article-title":"Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation","volume":"48","author":"M Gasparini","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/clc.20161","article-title":"Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy","volume":"31","author":"YH Jeong","year":"2008","journal-title":"Clin Cardiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.jacc.2012.08.977","article-title":"New unipolar electrogram criteria to identify irreversibility of nonischemic left ventricular cardiomyopathy","volume":"60","author":"B Campos","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.hrthm.2013.06.019","article-title":"Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation","volume":"10","author":"LH Ling","year":"2013","journal-title":"Heart Rhythm"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","article-title":"Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI Study","volume":"70","author":"S Prabhu","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"40378","DOI":"10.1038\/srep40378","article-title":"Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation","volume":"7","author":"D Hern\u00e1ndez-Romero","year":"2017","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"E976","DOI":"10.3390\/ijms19040976","article-title":"Galectin-3 in atrial fibrillation: mechanisms and therapeutic implications","volume":"19","author":"N Clementy","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"JE Ho","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1373\/clinchem.2011.174359","article-title":"Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22","volume":"58","author":"EW Grandin","year":"2012","journal-title":"Clin Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"UC Sharma","year":"2004","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/01.RES.0000141019.20332.3e","article-title":"Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy","volume":"95","author":"B Schroen","year":"2004","journal-title":"Circ Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter Ablation for Atrial Fibrillation with Heart Failure","volume":"378","author":"NF Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/europace\/eux090","article-title":"The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation","volume":"20","author":"WR Berger","year":"2018","journal-title":"Europace"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0201517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T09:53:40Z","timestamp":1540202020000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0201517"}},"subtitle":[],"editor":[{"given":"Elena","family":"Cavarretta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0201517","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]}}}